Disposition of 10145 shares by Susan Dexter of Sonnet Biotherapeutics at 1.51 subject to Rule 16b-3
| 56S1 Stock | EUR 184.25 0.95 0.52% |
Roughly 52% of Sartorius Stedim's investor base is interested to short. The analysis of current outlook of investing in Sartorius Stedim Biotech suggests that many traders are impartial regarding Sartorius Stedim's prospects. The current market sentiment, together with Sartorius Stedim's historical and current headlines, can help investors time the market. In addition, many technical investors use Sartorius Stedim Biotech stock news signals to limit their universe of possible portfolio assets.
Sartorius Stedim stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Sartorius daily returns and investor perception about the current price of Sartorius Stedim Biotech as well as its diversification or hedging effects on your existing portfolios.
Sartorius |
Filed transaction by Sonnet Biotherapeutics Holdings Officer Chief Technical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Sartorius Stedim Fundamental Analysis
We analyze Sartorius Stedim's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Stedim using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Stedim based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Sartorius Stedim is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Sartorius Stedim Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sartorius Stedim stock to make a market-neutral strategy. Peer analysis of Sartorius Stedim could also be used in its relative valuation, which is a method of valuing Sartorius Stedim by comparing valuation metrics with similar companies.
Peers
Sartorius Stedim Related Equities
| OGM1 | Cogent Communications | 1.39 | ||||
| I9V | TITANIUM TRANSPORTGROUP | 1.34 | ||||
| 9YM | KRISPY KREME | 0.54 | ||||
| BAC | Bank of America | 0.49 | ||||
| FUY | Fukuyama Transporting | 0.89 | ||||
| 9GY | USWE SPORTS | 1.35 | ||||
| 6IC | Iridium Communications | 1.45 |
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |